We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.78%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$2.65B
AUM Growth
+$204M
(+8.3%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
6.37%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
1,382
New
147
Increased
717
Reduced
389
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VER
VEREIT, Inc.
VER
|
+$13.6M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$7.94M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$7.84M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$5.92M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$5.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$8.42M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$4.06M |
| 4 |
Vodafone
VOD
|
+$3.25M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 6.24% |
| 2 | Financials | 4.98% |
| 3 | Technology | 4.69% |
| 4 | Healthcare | 4.57% |
| 5 | Industrials | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares S&P 100 ETF
OEF
$20.5B
| $19M | 0.72% |
229,175
+3,205
| +1% | +$261K |
|
27
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $18.4M | 0.7% |
314,443
+31,236
| +11% | +$1.8M |
|
|
28
Johnson & Johnson
JNJ
$627B
| $18.1M | 0.68% |
184,443
-90,863
| -33% | -$8.42M |
|
29
Berkshire Hathaway Class B
BRK.B
$1.15T
| $18M | 0.68% |
143,647
+14,601
| +11% | +$1.71M |
|
30
Chevron
CVX
$378B
| $17.3M | 0.65% |
145,655
+9,021
| +7% | +$1.05M |
|
31
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $17.3M | 0.65% |
201,038
+2,702
| +1% | +$228K |
|
32
SPDR Gold Trust
GLD
$142B
| $17.3M | 0.65% |
139,667
-5,758
| -4% | -$718K |
|
|
33
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $17.2M | 0.65% |
440,945
+205,391
| +87% | +$7.84M |
|
34
Vanguard Morningstar Small-Cap ETF
VB
$82.5B
| $16.6M | 0.63% |
147,254
+8,603
| +6% | +$953K |
|
35
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $16.6M | 0.63% |
559,090
+96,406
| +21% | +$2.82M |
|
36
Verizon
VZ
$194B
| $15.7M | 0.6% |
330,969
+58,369
| +21% | +$2.76M |
|
37
iShares Russell 1000 Value ETF
IWD
$84.2B
| $15.4M | 0.58% |
159,592
+10,939
| +7% | +$1.02M |
|
38
Invesco QQQ Trust
QQQ
$480B
| $15.3M | 0.58% |
174,307
+7,703
| +5% | +$681K |
|
39
Procter & Gamble
PG
$339B
| $14.9M | 0.56% |
184,835
+10,879
| +6% | +$857K |
|
40
IBM
IBM
$224B
| $13.6M | 0.52% |
74,083
+7,956
| +12% | +$1.4M |
|
41
Pfizer
PFE
$154B
| $13.5M | 0.51% |
444,225
+7,640
| +2% | +$228K |
|
42
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $13.4M | 0.51% |
326,197
-7,758
| -2% | -$304K |
|
43
Bank of America
BAC
$447B
| $13.4M | 0.51% |
776,926
+75,978
| +11% | +$1.28M |
|
|
44
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $13.3M | 0.5% |
510,897
+231,329
| +83% | +$5.92M |
|
45
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
| $12.5M | 0.47% |
171,247
+17,138
| +11% | +$1.22M |
|
46
Microsoft
MSFT
$3.78T
| $12.1M | 0.46% |
296,200
+23,794
| +9% | +$893K |
|
47
Altria Group
MO
$112B
| $11.9M | 0.45% |
318,591
+4,980
| +2% | +$181K |
|
48
iShares Core S&P Small-Cap ETF
IJR
$112B
| $11.6M | 0.44% |
210,640
+26,364
| +14% | +$1.43M |
|
49
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $11.4M | 0.43% |
45,441
+2,685
| +6% | +$658K |
|
50
Invesco S&P 500 Low Volatility ETF
SPLV
$7.18B
| $11.3M | 0.43% |
332,898
+88,698
| +36% | +$2.92M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, Cambridge Investment Research Advisors held 1,382 positions worth $2.65B, up 8.3% from $2.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Cambridge Investment Research Advisors deployed $169M of net new capital in Q1 2014, opening 147 new positions and adding to 717 existing holdings. Its largest new stake was Marvell Technology: 229,874 shares worth $3.62M.
By sector, the portfolio is most concentrated in Energy at 6.2% of assets, down from 6.4% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $15.7M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2014 buy was Marvell Technology: 229,874 shares worth $3.62M.
- Cambridge Investment Research Advisors added most to VEREIT, Inc. in Q1 2014, an estimated $13.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $15.7M.
- Cambridge Investment Research Advisors fully exited Vodafone in Q1 2014, selling an estimated $3.25M.
- Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $2.65B portfolio in Q1 2014.
- Cambridge Investment Research Advisors opened 147 new positions and closed 89 in Q1 2014.
- Cambridge Investment Research Advisors's portfolio value rose 8.3% quarter-over-quarter to $2.65B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2014, filed 29 Apr 2014.